Cargando…
Nanomedicine for Combination Urologic Cancer Immunotherapy
Urologic cancers, particularly kidney, bladder, and prostate cancer, have a growing incidence and account for about a million annual deaths worldwide. Treatments, including surgery, chemotherapy, radiotherapy, hormone therapy, and immunotherapy are the main therapeutic options in urologic cancers. I...
Autores principales: | Tian, Yun, Liu, Zhenzhu, Wang, Jianbo, Li, Linan, Wang, Fuli, Zhu, Zheng, Wang, Xuejian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960671/ https://www.ncbi.nlm.nih.gov/pubmed/36839868 http://dx.doi.org/10.3390/pharmaceutics15020546 |
Ejemplares similares
-
Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine
por: Yun, Tian, et al.
Publicado: (2022) -
Light-responsive nanomedicine for cancer immunotherapy
por: Kang, Weirong, et al.
Publicado: (2023) -
Recent Advances in Engineering Nanomedicines for Second Near-Infrared Photothermal-Combinational Immunotherapy
por: Wang, Fengshuo, et al.
Publicado: (2022) -
Enhancing Combined Immunotherapy and Radiotherapy
through Nanomedicine
por: Hagan, C. Tilden, et al.
Publicado: (2020) -
Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)